Subscribe to Newsletter

Refine results:

Refine results

White Papers

Results 11–20 of 124

Optimizing Downstream Processing for an Inactivated Rabies Vaccine

| Contributed by MilliporeSigma

While rabies is a preventable and curable disease, it continues to have an impact on human and animal health in developing countries.

How to Improve the Capturing of Antibody Fragments

| Contributed by Tosoh

We developed a capturing method for antibody fragments that allows reducing the costs of the step by almost 80%.

Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

Low levels of nitrosamine impurities that could be present in pharmaceutical products pose challenges for analytical laboratories.

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

To demonstrate fast, highly sensitive quantitation of nine nitrosamines with a Thermo Scientific Orbitrap Exploris 120 mass spectrometer

LC-MS/MS method for the quantification of 10 nitrosamine impurities in metformin

| Contributed by Thermo Fisher Scientific

Separation of metformin and 10 nitrosamine impurities is realized by reversed-phase chromatography.

Accelerate innovation and manufacturing to better serve patients

| Contributed by GenScript Probio

Many advancements are ongoing in science and technology, and advanced medicinal products are essential for the treatment and prevention of diseases

Efficiencies in manufacturing

| Contributed by ACG

Granulation has been an integral process within pharmaceutical manufacturing for years

Discover the importance of early form screening in JM's insightful white paper

| Contributed by Johnson Matthey

Early identification of potential issues within an API’s solid form can accelerate time to market and reduce associated costs.

Simple and Effective Method for Purification of DMT-ON Oligonucleotides using HIC Resins

| Contributed by Tosoh

The use of synthetic oligonucleotide therapeutics continues to grow because of their effectiveness in the treatment of devastating diseases.

Characterization of Recombinant Protein Biotherapeutics by UHPLC-SEC-MALS

| Contributed by Tosoh

Biotherapeutics are generally larger molecules such as peptides, proteins and monoclonal antibodies

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register